The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 727 KB) and Technical Notes (PDF, 1.1 MB) pages.

Download and Print: Download Printer-friendly PDF Download data

Table 1.22

U.S. Complete Prevalence Counts, Invasive Cancers Only, January 1, 2018a
By Age at Prevalence

Site Sex Age at Prevalence
All Agesc Ages
0-9		 Ages
10-19		 Ages
20-29		 Ages
30-39		 Ages
40-49		 Ages
50-59		 Ages
60-69		 Ages
70+
All Sites Males 7,505,669 19,862 49,240 96,083 180,670 335,822 909,233 1,971,545 3,943,213
Females 8,847,752 17,753 41,566 96,287 268,119 650,428 1,475,237 2,302,303 3,996,060
Oral Cavity & Pharynx Males 269,596 73 484 1,500 3,868 13,005 48,826 90,629 111,211
Females 127,341 38 526 1,677 3,761 8,853 20,939 33,857 57,690
Esophagus Males 38,335 0 0 27 161 969 4,638 12,150 20,390
Females 11,115 0 0 16 65 201 1,051 3,171 6,610
Stomach Males 68,418 0 33 160 931 2,864 8,900 18,019 37,512
Females 51,883 0 31 239 1,059 2,809 7,732 12,431 27,582
Colon & Rectum Males 684,455 8 658 1,921 8,059 27,902 98,969 176,027 370,911
Females 680,680 38 828 2,515 8,193 27,136 88,095 151,975 401,899
Liver & Intrahepatic Bile Duct Males 66,438 670 806 590 659 1,663 9,884 30,858 21,308
Females 29,740 575 733 421 682 1,150 4,070 10,305 11,805
Pancreas Males 41,865 14 73 122 606 1,893 6,875 13,689 18,592
Females 41,912 0 104 373 1,005 2,551 5,920 12,411 19,547
Larynx Males 78,352 0 5 79 333 1,448 8,233 22,428 45,826
Females 17,670 0 0 53 163 528 2,868 5,296 8,763
Lung & Bronchus Males 258,486 73 114 428 1,308 4,405 22,920 70,123 159,114
Females 324,145 74 80 490 1,576 5,917 31,857 82,223 201,928
Melanoma of the Skin Males 663,784 46 500 4,021 16,372 39,705 98,334 173,862 330,944
Females 631,102 126 746 7,416 33,393 66,792 126,331 160,996 235,302
Breast Males 20,786 0 0 4 153 573 2,317 4,929 12,810
Females 3,676,262 8 82 3,180 42,927 211,749 605,824 1,005,322 1,807,170
Cervix Females 293,394 0 33 1,511 14,936 39,664 64,977 74,049 98,224
Corpus & Uterus, NOS Females 813,861 0 44 894 7,867 30,259 101,835 238,387 434,574
Ovaryd Females 235,081 48 1,186 4,398 9,165 18,677 44,682 65,833 91,091
Prostate Males 3,245,430 32 61 81 142 11,967 207,046 855,584 2,170,516
Urinary Bladder Males 544,935 81 69 621 2,135 8,355 38,095 118,443 377,136
Females 178,810 33 82 274 1,004 2,909 12,556 35,885 126,067
Kidney & Renal Pelvis Males 356,913 1,494 2,197 2,587 9,229 23,570 58,084 100,411 159,341
Females 225,814 1,675 2,628 3,291 7,228 16,209 34,668 57,445 102,668
Hodgkin Lymphoma Males 112,578 169 2,333 10,026 15,925 20,933 27,090 21,569 14,532
Females 106,550 29 1,774 9,047 16,474 21,063 25,044 18,966 14,154
Non-Hodgkin Lymphoma Males 394,545 946 4,144 8,455 14,859 28,296 61,683 100,701 175,460
Females 348,631 524 1,900 4,969 10,369 21,583 49,290 86,675 173,321
Myeloma Males 83,038 0 8 72 702 3,692 11,948 24,947 41,669
Females 66,918 3 9 78 504 2,844 9,857 20,284 33,339
Leukemia Males 260,650 6,976 16,133 17,880 14,147 17,808 33,353 55,685 98,669
Females 198,408 6,391 12,430 14,279 12,520 14,524 23,954 38,278 76,033
Acute Lymphocytic Leukemia Males 56,452 5,705 13,467 13,809 9,153 7,129 4,281 1,912 994
Females 47,084 5,197 10,623 10,597 8,134 6,150 3,628 1,657 1,098

Footnotes:

a U.S. 2018 cancer prevalence counts are based on 2018 cancer prevalence proportions from the SEER 13 areas not including the Alaska Natives Registry (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, Rural Georgia, San Jose-Monterey, and Los Angeles) and 1/1/2018 U.S. population estimates based on the average of 2017 and 2018 population estimates from the U.S. Bureau of the Census. Prevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 26 years.

b Cases diagnosed more than 26 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

c Due to rounding, the sum of the age specific estimates may not equal the all ages estimate.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.